Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 12494

Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2025.

The global Dermatophytic Onychomycosis Therapeutics (DOT) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dermatophytic Onychomycosis Therapeutics (DOT) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dermatophytic Onychomycosis Therapeutics (DOT) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Galderma
Bausch Health
Novartis
Pfizer
Janssen
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Topical
Oral Therapy

Segment by Application
Hospitals
Dermatology And Podiatry Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores

Table of Contents

Executive Summary
1 Dermatophytic Onychomycosis Therapeutics (DOT) Market Overview
1.1 Product Overview and Scope of Dermatophytic Onychomycosis Therapeutics (DOT)
1.2 Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Type
1.2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Topical
1.2.3 Oral Therapy
1.3 Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Application
1.3.1 Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Dermatology And Podiatry Clinics
1.3.4 Independent Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Drug Stores
1.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market by Region
1.4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size
1.5.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue (2014-2025)
1.5.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production (2014-2025)

2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Competition by Manufacturers
2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Market Share by Manufacturers (2014-2019)
2.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Share by Manufacturers (2014-2019)
2.3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites, Area Served, Product Types
2.5 Dermatophytic Onychomycosis Therapeutics (DOT) Market Competitive Situation and Trends
2.5.1 Dermatophytic Onychomycosis Therapeutics (DOT) Market Concentration Rate
2.5.2 Dermatophytic Onychomycosis Therapeutics (DOT) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Market Share by Regions
3.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Market Share by Regions
3.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Regions (2014-2019)
3.3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Dermatophytic Onychomycosis Therapeutics (DOT) Production
3.4.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate (2014-2019)
3.4.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Production
3.5.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate (2014-2019)
3.5.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Dermatophytic Onychomycosis Therapeutics (DOT) Production (2014-2019)
3.6.1 China Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate (2014-2019)
3.6.2 China Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Production (2014-2019)
3.7.1 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate (2014-2019)
3.7.2 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption by Regions
4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption by Regions
4.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Consumption (2014-2019)
4.3 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Consumption (2014-2019)
4.4 China Dermatophytic Onychomycosis Therapeutics (DOT) Consumption (2014-2019)
4.5 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Consumption (2014-2019)

5 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price Trend by Type
5.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Market Share by Type (2014-2019)
5.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2014-2019)
5.3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Price by Type (2014-2019)
5.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth by Type (2014-2019)

6 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis by Applications
6.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Market Share by Application (2014-2019)
6.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Dermatophytic Onychomycosis Therapeutics (DOT) Business
7.1 Galderma
7.1.1 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
7.1.2 Dermatophytic Onychomycosis Therapeutics (DOT) Product Introduction, Application and Specification
7.1.3 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Bausch Health
7.2.1 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
7.2.2 Dermatophytic Onychomycosis Therapeutics (DOT) Product Introduction, Application and Specification
7.2.3 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Novartis
7.3.1 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
7.3.2 Dermatophytic Onychomycosis Therapeutics (DOT) Product Introduction, Application and Specification
7.3.3 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Pfizer
7.4.1 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
7.4.2 Dermatophytic Onychomycosis Therapeutics (DOT) Product Introduction, Application and Specification
7.4.3 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Janssen
7.5.1 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
7.5.2 Dermatophytic Onychomycosis Therapeutics (DOT) Product Introduction, Application and Specification
7.5.3 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served

8 Dermatophytic Onychomycosis Therapeutics (DOT) Manufacturing Cost Analysis
8.1 Dermatophytic Onychomycosis Therapeutics (DOT) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Dermatophytic Onychomycosis Therapeutics (DOT)
8.4 Dermatophytic Onychomycosis Therapeutics (DOT) Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Dermatophytic Onychomycosis Therapeutics (DOT) Distributors List
9.3 Dermatophytic Onychomycosis Therapeutics (DOT) Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Forecast
11.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue Forecast
11.1.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate Forecast (2019-2025)
11.1.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Price and Trend Forecast (2019-2025)
11.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Forecast by Regions (2019-2025)
11.2.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue Forecast (2019-2025)
11.2.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue Forecast (2019-2025)
11.2.3 China Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue Forecast (2019-2025)
11.2.4 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue Forecast (2019-2025)
11.3 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast by Regions (2019-2025)
11.3.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast (2019-2025)
11.3.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast (2019-2025)
11.3.3 China Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast (2019-2025)
11.3.4 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast (2019-2025)
11.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer